0.567
price up icon3.07%   0.0169
after-market Handel nachbörslich: .58 0.013 +2.29%
loading

Femasys Inc Aktie (FEMY) Neueste Nachrichten

pulisher
Mar 12, 2026

Femasys begins enrollment in pivotal trial for FemBloc device By Investing.com - Investing.com Nigeria

Mar 12, 2026
pulisher
Mar 12, 2026

Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN

Mar 12, 2026
pulisher
Mar 11, 2026

Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN

Mar 11, 2026
pulisher
Mar 10, 2026

Femasys begins enrollment in pivotal trial for FemBloc device - Investing.com

Mar 10, 2026
pulisher
Mar 10, 2026

Non-surgical permanent birth control FemBloc begins final U.S. trial - Stock Titan

Mar 10, 2026
pulisher
Mar 06, 2026

Femasys Inc. (NASDAQ:FEMY) Receives $5.50 Average Price Target from Analysts - Defense World

Mar 06, 2026
pulisher
Mar 04, 2026

Femasys (NASDAQ:FEMY) Now Covered by Analysts at Lake Street Capital - Defense World

Mar 04, 2026
pulisher
Mar 03, 2026

Lake Street initiates Femasys stock coverage with buy rating By Investing.com - Investing.com Australia

Mar 03, 2026
pulisher
Mar 03, 2026

Lake Street initiates Femasys stock coverage with buy rating - Investing.com

Mar 03, 2026
pulisher
Mar 01, 2026

FEMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026
pulisher
Feb 28, 2026

FEMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 28, 2026
pulisher
Feb 28, 2026

FEMY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 27, 2026
pulisher
Feb 27, 2026

Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health - TipRanks

Feb 27, 2026
pulisher
Feb 26, 2026

Femasys Announces FemBloc® Permanent Birth Control Has - GlobeNewswire

Feb 26, 2026
pulisher
Feb 26, 2026

New non-surgical permanent birth control clears key global quality hurdle - Stock Titan

Feb 26, 2026
pulisher
Feb 25, 2026

Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access - Bitget

Feb 25, 2026
pulisher
Feb 24, 2026

Sentiment Watch: Is Femasys Inc stock undervalued right nowJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

Femasys receives CPT code approval for infertility treatment - Investing.com India

Feb 24, 2026
pulisher
Feb 23, 2026

FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Femasys receives CPT code approval for infertility treatment By Investing.com - Investing.com South Africa

Feb 23, 2026
pulisher
Feb 23, 2026

Trend Review: Can Femasys Inc benefit from deglobalization2025 Big Picture & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 23, 2026

AMA procedure code supports new infertility option for over 10M US women - Stock Titan

Feb 23, 2026
pulisher
Feb 22, 2026

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination - Bitget

Feb 22, 2026
pulisher
Feb 20, 2026

Femasys (FEMY) CEO awarded 729,000 RSUs vesting through 2027 - Stock Titan

Feb 20, 2026
pulisher
Feb 20, 2026

Femasys (NASDAQ: FEMY) CFO receives 342,000 restricted stock units - Stock Titan

Feb 20, 2026
pulisher
Feb 17, 2026

Femasys (FEMY) CTO reports common stock and option holdings in Form 3 - Stock Titan

Feb 17, 2026
pulisher
Feb 14, 2026

How cyclical is Femasys Inc.’s revenue streamJuly 2025 News Drivers & Technical Pattern Based Buy Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Femasys : Shareholder Update – 2025 in Review - marketscreener.com

Feb 13, 2026
pulisher
Feb 11, 2026

Can Femasys Inc. sustain its profitabilityJuly 2025 Weekly Recap & Risk Managed Investment Strategies - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Forecast Cut: What dividend growth rate does Femasys Inc offerMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 04, 2026

Femasys stock rises on new distribution partnership in Switzerland By Investing.com - Investing.com Australia

Feb 04, 2026
pulisher
Feb 03, 2026

Femasys expands European presence with Swiss distribution deal By Investing.com - Investing.com Nigeria

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys Inc. Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys stock rises on new distribution partnership in Switzerland - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys expands European presence with Swiss distribution deal - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - The Manila Times

Feb 03, 2026
pulisher
Feb 03, 2026

Femasys Inc. Expands European Presence with New Distribution Partnership in Switzerland - Quiver Quantitative

Feb 03, 2026
pulisher
Feb 01, 2026

Insider Sell: Is Omega Healthcare Investors Inc subject to activist investor interest2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Trading Action: Can Femasys Inc sustain its profitabilityTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Femasys Secures Major Order for FemBloc Launch - MSN

Jan 31, 2026
pulisher
Jan 20, 2026

Travel Stocks: What is PCARs revenue forecastEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 16, 2026

Returns Recap: Does Ares Management Corporation meet Warren Buffetts criteria2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

Femasys Receives Nasdaq Extension to Regain Listing Compliance - The Globe and Mail

Jan 16, 2026
pulisher
Jan 15, 2026

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule - Investing.com

Jan 15, 2026
pulisher
Jan 15, 2026

Femasys Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Jan 15, 2026
pulisher
Jan 15, 2026

Stock Recap: Will FUFU benefit from geopolitical trendsCPI Data & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Sahm

Jan 15, 2026
$66.76
price up icon 0.97%
$164.23
price down icon 1.61%
medical_instruments_supplies COO
$69.92
price down icon 2.24%
$75.12
price down icon 0.12%
medical_instruments_supplies WST
$235.46
price up icon 1.89%
medical_instruments_supplies RMD
$230.84
price down icon 0.68%
Kapitalisierung:     |  Volumen (24h):